Eye drop’s claim to replace glasses cost it the launch & sale nod. The controversy & safety concerns
New Delhi: Last week, the Central Drugs Standard Control Organisation (CDSCO), India’s apex drug regulator, revoked the authorisation issued to Mumbai-based Entod Pharmaceuticals to manufacture and market an eye drop, …